Fwd: CTSU SOP

0 views
Skip to first unread message

THANGARAJAN RAJKUMAR

unread,
Dec 30, 2022, 12:03:34 AM12/30/22
to ci-molecul...@googlegroups.com

---------- Forwarded message ---------
From: Director Secretariat <director.s...@cancerinstitutewia.org>
Date: Fri, 30 Dec 2022, 09:35
Subject: CTSU SOP
To: krishmanju12 <krishm...@yahoo.com>, drtrajkumar <drtra...@gmail.com>, alexander john <onco...@yahoo.co.in>, Venkatraman Radhakrishnan <ven...@gmail.com>, Jayachandran P K <dr.pkjay...@gmail.com>, Nikita Mehra <nikita...@gmail.com>, gangothri selvarajan <gango...@gmail.com>, Parathan Karunakaran <drpar...@gmail.com>, sivasree kesana <sivasre...@gmail.com>, Indhu Ja <mvssi...@gmail.com>, <drbal...@gmail.com>, <prasant...@gmail.com>, <gargi....@gmail.com>, <akhil...@gmail.com>, <thiya...@gmail.com>, Dr. Krishnarathnam - <kri...@hotmail.com>, <subas...@gmail.com>, <doc.ch...@gmail.com>, <cardiolog...@gmail.com>, Arvind Krishnamurthy <drarvindkr...@yahoo.co.in>, sri04devi <sri0...@yahoo.co.in>, ram_a_s <ram...@yahoo.com>, <dr_a...@yahoo.com>, <venkte...@yahoo.com>, Dr. Ujwala Wakpaijan <drujwal...@gmail.com>, <chand...@gmail.com>, Vijay Sundar <drvija...@gmail.com>, <jose...@gmail.com>, <dr_aru...@yahoo.com>, Uma Madesh <umades...@yahoo.com>, kamakshi k <kmak...@gmail.com>, <shruthiina...@gmail.com>, <vassnthj...@gmail.com>, <drbel...@gmail.com>, <drjagan...@gmail.com>, <dr.pradee...@gmail.com>, Arun Mitra <arunm...@gmail.com>, vivekpatel0709 <vivekpa...@gmail.com>, <kingst...@gmail.com>, <jrohi...@gmail.com>, <dranjana...@hotmail.com>, <hanu...@gmail.com>, <anith...@gmail.com>, Thirumoorthi Maheswari <tiru...@gmail.com>, <drsuj...@gmail.com>, <ravik...@gmail.com>, <aic...@gmail.com>, <dr.ar...@gmail.com>, <hari...@gmail.com>, <arkart...@yahoo.com>, Meenakshi V.V <meena...@yahoo.com>, <nairi...@gmail.com>, Nivedhyaa Raghavan <nive...@gmail.com>, <poor...@gmail.com>, prasanna vani <prasn...@gmail.com>, <pritha...@yahoo.co.in>, punitha arivazhagan <punit...@gmail.com>, <sahithya...@gmail.com>, <drs...@gmail.com>, <thendr...@yahoo.com>, <vallar...@gmail.com>, <kausalyav...@gmail.com>, <drsrikan...@gmail.com>, <dr.j....@gmail.com>, Ananthi Balasubramanian <b.an...@cancerinstitutewia.org>, Arun Kumar <draru...@gmail.com>, Priya Iyer <priy...@gmail.com>, Christopher Vasanth <jcv...@gmail.com>, <ramanak...@yahoo.co.in>, <hharis...@yahoo.co.in>, <hhari...@gmail.com>, Ram Madhavan <ramump...@gmail.com>, Vengada Krishnan <vengada...@gmail.com>, Gautam Vydia <gauta...@gmail.com>, <mkousa...@gmail.com>, <drdinny...@gmail.com>, <priya....@yahoo.com>, sadan S <ss.sa...@gmail.com>, <rk.sa...@gmail.com>, Surendran V <v.sur...@cancerinstitutewia.org>, <ramar...@yahoo.com>, Vijay Srinivasan <svij...@yahoo.com>, Satish MS <ms.s...@cancerinstitutewia.org>, Clinical Trial Services Unit Cancer Institute (W.I.A) <ct...@cancerinstitutewia.org>, Institute Ethics Committee <i...@cancerinstitutewia.org>, Shirley Sundersingh <drshirleys...@gmail.com>, Samson Mani <sams...@gmail.com>, balaji ramachandran <bala...@gmail.com>, Dr. Priya <priya_...@yahoo.co.in>, mayil vahanan <go2m...@gmail.com>, Deva Magendhra Rao <akdmr26n...@gmail.com>, <hemm...@gmail.com>, <kmur...@rediffmail.com>, Sithara Venkateshwar <sitharave...@gmail.com>, swathy umasankar <swathyum...@gmail.com>, Jhansi A <drjh...@gmail.com>, karthik bommannan <bkk...@gmail.com>, <drcha...@gmail.com>, <kashyop...@gmail.com>, <gdeep...@yahoo.co.in>, drswapna. swapna y <drsw...@gmail.com>, <atre...@gmail.com>
Cc: Executive Vice-Chairman <e...@cancerinstitutewia.org>, G Selvaluxmy <dire...@cancerinstitutewia.org>, Kalpana balakrishnan <kalpana.ba...@gmail.com>, Swaminathan Rajaraman <r.swam...@cancerinstitutewia.org>, Varalakshmi Vijayakumar <vaar...@gmail.com>


CANCER INSTITUTE (WIA)

ADYAR, CHENNAI - 20 

 

CIRCULAR NO.122/2022-23, DATED 30.12.2022

 

Dear All,

Please find attached CTSU SOP Version 02  dated 23 Dec 2022 for your reference.

Kindly follow the SOP instructions of the Clinical Trial Services unit for your ongoing/Upcoming Trial requirements.


Dr.G.Selvaluxmy
Director
CTSU-SOP Version 02 dated 23 Dec 2022.pdf
Reply all
Reply to author
Forward
0 new messages